The ability to efficiently isolate and expand various stem cell populations in vitro is crucial for successful translation of cell-based therapies to the clinical setting. One such heterogeneous population that possesses a remarkable potential for the development of cell-based treatments for a variety of degenerative diseases and disorders is called the Side Population (SP). For many years, investigators have isolated these primitive cells based upon their ability to efflux the fluorophore Hoechst 33342. This attribute enabled separation of SP cells derived from multiple tissue sources from other endogenous cell populations using fluorescence-activated cell sorting (FACS). While all tissue-specific SP fractions appear to contain cells with multi-potent stem cell activity, the therapeutic utility of these cells has yet to be fully realized because of the scarcity of this fraction in vivo. In view of that, we developed a method to expand adult murine bone marrow and skeletal muscle-derived SP cells in vitro. Here, we describe a spinner-flask culture system that supports the growth of SP cells in suspension when they are combined with feeder cells cultured on spherical microcarriers. In this way, their distinguishing biological characteristics can be maintained, attachment-stimulated differentiation is avoided, and therapeutically relevant quantities of SP cells are generated. Modification of the described procedure may permit expansion of the SP from other relevant tissue sources and our method is amenable to establishing compliance with current good manufacturing practices.
Side population cells SP cells Adult stem cells Cell expansion Microcarrier Skeletal muscle Bone marrow Spinner flasks Suspension culture
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
Funding was provided by a grant from the National Institutes of Health (HL088206), a Grant-in-Aid from the American Heart Association (12GRNT11910008), the Children’s Hospital Medical Corporation Anesthesia Foundation, a grant from the Children’s Heart Foundation and donations to the Cardiac Conduction Fund, the Ryan Family Fund, and by David Pullman.
Itescu S, Schuster MD, Kocher AA (2003) New directions in strategies using cell therapy for heart disease. J Mol Med 81:288–296PubMedGoogle Scholar
Bachrach E, Li S, Perez AL et al (2004) Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci U S A 101:3581–3586PubMedCentralPubMedCrossRefGoogle Scholar
Montanaro F, Liadaki K, Schienda J et al (2004) Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res 298:144–154PubMedCrossRefGoogle Scholar
Majka SM, Jackson KA, Kienstra KA et al (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111:71–79PubMedCentralPubMedCrossRefGoogle Scholar
Meeson AP, Hawke TJ, Graham S et al (2004) Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells 22:1305–1320PubMedCrossRefGoogle Scholar
Hierlihy AM, Seale P, Lobe CG et al (2002) The post-natal heart contains a myocardial stem cell population. FEBS Lett 530:239–243PubMedCrossRefGoogle Scholar
McKinney-Freeman SL, Majka SM, Jackson KA et al (2003) Altered phenotype and reduced function of muscle-derived hematopoietic stem cells. Exp Hematol 31:806–814PubMedCrossRefGoogle Scholar
Tamaki T, Akatsuka A, Okada Y et al (2003) Growth and differentiation potential of main- and side-population cells derived from murine skeletal muscle. Exp Cell Res 291:83–90PubMedCrossRefGoogle Scholar
Tamaki T, Akatsuka A, Ando K et al (2002) Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157:571–577PubMedCentralPubMedCrossRefGoogle Scholar
Nadin BM, Goodell MA, Hirschi KK (2003) Phenotype and hematopoietic potential of side population cells throughout embryonic development. Blood 102:2436–2443PubMedCrossRefGoogle Scholar